6 completed, 1 active not recruiting, 1 enrolling by invitation, 1 unknown. 4 Phase 3, 2 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Not applicable | 2 | Completed 2 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Vasomotor Symptoms Associated With Menopause: new trials by email Literature Review of Vasomotor Symptoms Associated With Menopause trials Research Report on Vasomotor Symptoms Associated With Menopause
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY) Perimenopause, Perimenopause-Related Depression | Enrolling by invitation | Healing Hope International | 12 | 2026-06-01 | 2026-04-06 | |
| Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause ABCL635, Placebo - Vasomotor Symptoms Associated With Menopause, Healthy Volunteers | Phase 1 / Phase 2 | Active not recruiting | AbCellera Biologics Inc. | 136 | 2025-06-23 | 2026-10-27 |
| A Feasibility Study of a Group Talking Therapy Programme for NHS Staff With Menopausal Hot Flushes and Night Sweats. Cognitive Behavioral therapy group programme for Menopausal Hot flushes and Night Sweats, No intervention - Vasomotor Symptoms Associated With Menopause | Not applicable | Completed | Queen's University, Belfast | 35 | 2025-05-08 | 2026-08-12 |
| Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women JDS-HF3.0 - Hot Flashes, Hot Flash | Not applicable | Completed | Bonafide Health | 112 | 2024-05-24 | 2026-02-12 |
| A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2) Elinzanetant (BAY3427080), Placebo - Vasomotor Symptoms Associated With Menopause, Hot Flashes | Phase 3 | Completed | Bayer | 400 | 2021-10-29 | 2026-02-12 |
| A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause Elinzanetant (BAY3427080), Placebo - Vasomotor Symptoms Associated With Menopause, Hot Flashes | Phase 3 | Completed | Bayer | 628 | 2021-08-27 | 2025-12-01 |
| A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause Elinzanetant (BAY3427080), Placebo - Vasomotor Symptoms Associated With Menopause, Hot Flashes | Phase 3 | Completed | Bayer | 396 | 2021-08-27 | 2026-02-12 |
| Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause Bazedoxifene/Conjugated Estrogen - Vasomotor Symptoms Associated With Menopause | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 325 | 2005-10-01 | 2007-12-28 |
| Herbal Alternatives for Menopause Symptoms (HALT Study) Black cohosh, Multibotanical preparation, Multibotanical preparation + dietary soy counseling - Vasomotor Symptoms Associated With Menopause | Phase 4 | Unknown | Kaiser Permanente | 351 | 2001-06-01 | 2005-09-15 |
Hot Flashes (7) · Endocrine System Diseases (1) · Multiple Endocrine Neoplasia Type 1 (1) · Primary Ovarian Insufficiency (1)
Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Adnexal Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Gonadal Disorders (1) · Multiple Endocrine Neoplasia (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Multiple Primary (1)
Estrogens, Conjugated (USP) (1) · bazedoxifene (1) · black cohosh root extract (1)
Bayer (3) · AbCellera Biologics Inc. (1) · Bonafide Health (1) · Healing Hope International (1) · Kaiser Permanente (1) · Queen's University, Belfast (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (6) · Canada (3) · Czechia (2) · Italy (2) · Poland (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Denmark (1) · Finland (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1)
Dr. Jonatha Leicher, MD: Regenerative Medicine (1) · Eric Sicard (1) · Katherine M Newton, PhD (1) · Katrina McLaughlin, P.hD (1) · Orla E Walsh, Bsc, Msc (1)